Chengyi Peng

685 total citations
11 papers, 523 citations indexed

About

Chengyi Peng is a scholar working on Molecular Biology, Pharmacology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Chengyi Peng has authored 11 papers receiving a total of 523 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Pharmacology and 3 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Chengyi Peng's work include Natural Antidiabetic Agents Studies (3 papers), Berberine and alkaloids research (2 papers) and Cardiac Fibrosis and Remodeling (2 papers). Chengyi Peng is often cited by papers focused on Natural Antidiabetic Agents Studies (3 papers), Berberine and alkaloids research (2 papers) and Cardiac Fibrosis and Remodeling (2 papers). Chengyi Peng collaborates with scholars based in China. Chengyi Peng's co-authors include Hu Ju, Qinwan Huang, Qingxia Gan, Haijun Xiong, Guanhua Lou, Jin Wang, Qian Ran, Jilin Sun, Li Wang and Lin Li and has published in prestigious journals such as Journal of Agricultural and Food Chemistry, Molecules and Frontiers in Pharmacology.

In The Last Decade

Chengyi Peng

10 papers receiving 516 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chengyi Peng China 9 219 100 87 65 64 11 523
Jinbin Wei China 19 312 1.4× 104 1.0× 69 0.8× 71 1.1× 70 1.1× 54 806
Jingda Li China 12 286 1.3× 78 0.8× 109 1.3× 70 1.1× 80 1.3× 27 688
P.-D.L. Chao Taiwan 11 167 0.8× 88 0.9× 78 0.9× 49 0.8× 68 1.1× 31 484
Khalid Ghazanfar India 9 169 0.8× 89 0.9× 156 1.8× 49 0.8× 45 0.7× 16 553
Mohamed A. Kandeil Egypt 16 304 1.4× 100 1.0× 67 0.8× 32 0.5× 45 0.7× 44 872
Shaymaa A. Abdulmalek Egypt 15 162 0.7× 56 0.6× 77 0.9× 41 0.6× 43 0.7× 35 551
Pritam Bhagwan Bhosale South Korea 13 280 1.3× 96 1.0× 43 0.5× 94 1.4× 82 1.3× 37 592
Andreea Liana Răchişan Romania 8 141 0.6× 59 0.6× 62 0.7× 100 1.5× 49 0.8× 25 523
Aristatile Balakrishnan Saudi Arabia 14 164 0.7× 108 1.1× 98 1.1× 57 0.9× 42 0.7× 24 555
Weronika Wojnar Poland 14 183 0.8× 72 0.7× 96 1.1× 57 0.9× 51 0.8× 21 478

Countries citing papers authored by Chengyi Peng

Since Specialization
Citations

This map shows the geographic impact of Chengyi Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengyi Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengyi Peng more than expected).

Fields of papers citing papers by Chengyi Peng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chengyi Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengyi Peng. The network helps show where Chengyi Peng may publish in the future.

Co-authorship network of co-authors of Chengyi Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Chengyi Peng. A scholar is included among the top collaborators of Chengyi Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chengyi Peng. Chengyi Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
3.
Lou, Guanhua, Jin Wang, Hu Ju, et al.. (2021). Sanguinarine: A Double-Edged Sword of Anticancer and Carcinogenesis and Its Future Application Prospect. Anti-Cancer Agents in Medicinal Chemistry. 21(16). 2100–2110. 18 indexed citations
4.
Lou, Guanhua, Haijun Xiong, Qingxia Gan, et al.. (2021). UPLC-Q-Orbitrap HRMS Analysis of Coptis chinensis Aerial Parts and Its Regulatory Activity on Glucose-lipid Metabolism. Revista Brasileira de Farmacognosia. 31(1). 24–31. 4 indexed citations
5.
Ju, Hu, Jin Wang, Qingxia Gan, et al.. (2020). Impact of Red Yeast Rice on Metabolic Diseases: A Review of Possible Mechanisms of Action. Journal of Agricultural and Food Chemistry. 68(39). 10441–10455. 30 indexed citations
6.
Gan, Qingxia, Jin Wang, Hu Ju, et al.. (2020). Modulation of Apoptosis by Plant Polysaccharides for Exerting Anti-Cancer Effects: A Review. Frontiers in Pharmacology. 11. 792–792. 44 indexed citations
7.
Xiong, Haijun, Jin Wang, Qian Ran, et al.. (2019). <p>Hesperidin: A Therapeutic Agent For Obesity</p>. Drug Design Development and Therapy. Volume 13. 3855–3866. 153 indexed citations
8.
Gan, Qingxia, Jin Wang, Hu Ju, et al.. (2019). The role of diosgenin in diabetes and diabetic complications. The Journal of Steroid Biochemistry and Molecular Biology. 198. 105575–105575. 87 indexed citations
9.
Gu, Xin, Chengyi Peng, Shiyu Lin, et al.. (2019). P16INK4a played a critical role in exacerbating acute tubular necrosis in acute kidney injury.. PubMed. 11(6). 3850–3861. 16 indexed citations
10.
Fan, Wenxiang, Linhong Fan, Chengyi Peng, et al.. (2019). Traditional Uses, Botany, Phytochemistry, Pharmacology, Pharmacokinetics and Toxicology of Xanthium strumarium L.: A Review. Molecules. 24(2). 359–359. 107 indexed citations
11.
Du, Yingqiang, Xin Gu, Haoyu Meng, et al.. (2018). Muscone improves cardiac function in mice after myocardial infarction by alleviating cardiac macrophage-mediated chronic inflammation through inhibition of NF-κB and NLRP3 inflammasome.. PubMed. 10(12). 4235–4246. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026